Following receipt of dupilumab for 24 weeks, desensitization to peanut exposure in most children/adolescents with peanut ...
More information: Mark Boguniewicz et al, Dupilumab is Efficacious in Young Children with Atopic Dermatitis Regardless of Type 2 Comorbidities, Advances in Therapy (2024). DOI: 10.1007/s12325-024 ...
Hosted on MSN2mon
Dupilumab improves symptoms of atopic dermatitis in children with co-existing conditionsDupilumab had previously been shown to be effective in the treatment of atopic dermatitis, but this research is the first to examine the drug's efficacy in children with atopic dermatitis and co ...
Further information NICE will not progress with an appraisal for this indication due to positive guidance in the adult population within TA534. NHS England and Improvement will commission treatments ...
Further information NICE will not progress with an appraisal for this indication due to positive guidance in the adult population within TA751. NHS England and Improvement will commission treatments ...
Patients with atopic dermatitis using dupilumab vs conventional drugs had less risk for psychiatric and sleep disorders.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback